Fady M Kaldas

11PUBLICATIONS
18CO-AUTHORS
HaematologyRegenerative medicine (incl. stem cells)Haematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 27, 2026
Low-dose tissue plasminogen activator is safe and effective in treating major intracardiac thrombosis in liver transplant recipients.

|Jan 31, 2026
Normothermia Machine Perfusion Is Associated With Reduced Transfusion Requirements, Improved Hemodynamic Stability, and Decreased Vasopressor Use During the Postreperfusion Phase of Liver Transplantation.

Xian Zhao, Samer Ebaid, Nickolas Feduska

|Jul 23, 2025
Impact of Normothermic Machine Perfusion on Access to Liver Transplantation in Patients With Primary Hepatic Malignancies.

Dominic Amara, Andrew Melehy, Samer Ebaid

|Nov 15, 2023
Utility of preoperative troponin I to predict mortality in adult liver transplant recipients: Revisiting pretransplant cardiac risk in the current MELD-allocation era.

Christopher L Wray, Victor W Xia, Brent D Ershoff

|Aug 02, 2023
Alternative splicing of CEACAM1 by hypoxia-inducible factor-1α enhances tolerance to hepatic ischemia in mice and humans.

Kenneth J Dery, Hidenobu Kojima, Shoichi Kageyama

|Mar 03, 2022
New ERAS in liver transplantation - Past, present, and next steps.

Vivienne N Hannon, Pascale Tinguely, Greg J McKenna

Pageof 2

Frequent Collaborators

3 joint publications

Christopher Wray

3 joint publications

Victor Xia

2 joint publications

Jerzy W Kupiec-Weglinski

2 joint publications

Joseph DiNorcia